Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Polizzotto

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Scientific Data|November 11, 2022
The Health Gym: synthetic health-related datasets for the development of reinforcement learning algorithmsNicholas I-Hsien Kuo, Mark N Polizzotto, Simon Finfer, et al.
Transfusion|November 17, 2010
Hospital blood bank information systems accurately reflect patient transfusion: results of a validation studyZoe K McQuilten, Nikita Schembri, Mark N Polizzotto, et al.
The Journal of Infectious Diseases|March 27, 2012
Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndromeAlex Ray, Vickie Marshall, Thomas Uldrick, et al.
Cancer|March 20, 2014
Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage studyZoe K McQuilten, Erica M Wood, Mark N Polizzotto, et al.
The Journal of Infectious Diseases|August 24, 2014
A multiplex panel of plasma markers of immunity and inflammation in classical kaposi sarcomaPeter V Aka, Troy J Kemp, Charles S Rabkin, et al.
AIDS (London, England)|August 3, 2023
Associations of functional human leucocyte antigen class I groups with HIV viral load in a heterogeneous cohortAdrian G Zucco, Marc Bennedbæk, Christina Ekenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV InfectionRamya Ramaswami, Mark N Polizzotto, Kathryn Lurain, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 4, 2014
A sensitive and robust HPLC assay with fluorescence detection for the quantification of pomalidomide in human plasma for pharmacokinetic analysesShandiz Shahbazi, Cody J Peer, Mark N Polizzotto, et al.
Journal of Virology|October 23, 2015
Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1Duosha Hu, Victoria Wang, Min Yang, et al.
The Lancet. Microbe|April 7, 2024
Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysisKaren M Elias, Shanchita R Khan, Eva Stadler, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Scientific Data|November 11, 2022
The Health Gym: synthetic health-related datasets for the development of reinforcement learning algorithmsNicholas I-Hsien Kuo, Mark N Polizzotto, Simon Finfer, et al.
Transfusion|November 17, 2010
Hospital blood bank information systems accurately reflect patient transfusion: results of a validation studyZoe K McQuilten, Nikita Schembri, Mark N Polizzotto, et al.
The Journal of Infectious Diseases|March 27, 2012
Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndromeAlex Ray, Vickie Marshall, Thomas Uldrick, et al.
Cancer|March 20, 2014
Underestimation of myelodysplastic syndrome incidence by cancer registries: Results from a population-based data linkage studyZoe K McQuilten, Erica M Wood, Mark N Polizzotto, et al.
The Journal of Infectious Diseases|August 24, 2014
A multiplex panel of plasma markers of immunity and inflammation in classical kaposi sarcomaPeter V Aka, Troy J Kemp, Charles S Rabkin, et al.
AIDS (London, England)|August 3, 2023
Associations of functional human leucocyte antigen class I groups with HIV viral load in a heterogeneous cohortAdrian G Zucco, Marc Bennedbæk, Christina Ekenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2021
Safety, Activity, and Long-term Outcomes of Pomalidomide in the Treatment of Kaposi Sarcoma among Individuals with or without HIV InfectionRamya Ramaswami, Mark N Polizzotto, Kathryn Lurain, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 4, 2014
A sensitive and robust HPLC assay with fluorescence detection for the quantification of pomalidomide in human plasma for pharmacokinetic analysesShandiz Shahbazi, Cody J Peer, Mark N Polizzotto, et al.
Journal of Virology|October 23, 2015
Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Viral Interleukin-6 by X-Box Binding Protein 1Duosha Hu, Victoria Wang, Min Yang, et al.
The Lancet. Microbe|April 7, 2024
Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: a systematic review and meta-analysisKaren M Elias, Shanchita R Khan, Eva Stadler, et al.
Pageof 9